United States· US:27241-029_e627be01-7cc1-4a03-a183-1a5cfe92f9f0
Omeprazole and Sodium Bicarbonate
A medicinal product containing omeprazole; sodium bicarbonate, registered in United States by Ajanta Pharma USA Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OMEPRAZOLE; SODIUM BICARBONATE
- Manufacturer
- Ajanta Pharma USA Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1127241-029-31
- ndc1127241-029-62
- ndc11272410293130 FOR SUSPENSION in 1 CARTON (27241-029-31)
- ndc1127241029621 FOR SUSPENSION in 1 PACKET (27241-029-62)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f00b57a0-9d27-498d-b9ad-99b7dd3c81b8 GET /v1/drugs/f00b57a0-9d27-498d-b9ad-99b7dd3c81b8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "20; 1680",
"substance": "OMEPRAZOLE; SODIUM BICARBONATE",
"productndc": "27241-029",
"dosage_form": "FOR SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA205545",
"marketing_category": "ANDA"
}See everything about omeprazole; sodium bicarbonate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.